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Background: The purpose of this study was to report on the incidence and treatment outcomes 
of endogenous endophthalmitis among newborns in the neonatal intensive care unit (NICU) 
of a single medical center.
Methods: This was a noncomparative, retrospective case series of endogenous endophthalmitis 
among infants at the Jackson Memorial Hospital NICU treated between March 1, 2002 and 
March 1, 2007.
Results: Of 4323 infants admitted to the NICU, seven eyes of six (0.139%) infants (two males, 
four females) were diagnosed with endophthalmitis during the study period. Four patients were 
born prematurely with a mean gestational age of 27.5 weeks and a mean birth weight of 1153 g. 
Retinopathy of prematurity was reported in two of the six patients. Mean follow-up was 3.5 years. 
The diagnosis was confirmed by positive cultures or polymerase chain reaction testing at a median 
age of 34 postnatal days. Positive cultures included Candida albicans (n = 4), Pseudomonas 
aeruginosa (n = 1), and Herpes simplex type 2 (n = 1). All patients received systemic treatment 
and five received adjunctive ophthalmic interventions, including intravitreal antibiotics in five eyes 
of four patients and vitrectomy with pars plana lensectomy in three eyes. One patient underwent 
primary enucleation and another had delayed evisceration. In the remaining five eyes, there was 
a normal appearing posterior segment and normal intraocular pressures at last follow-up.
Conclusion: Endogenous endophthalmitis is a rare complication in infants in the NICU, but 
may occur in patients with candidemia, bacteremia, retinopathy of prematurity, and low birth 
weight. Despite early and appropriate treatment, involved eyes may have poor outcomes.
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Introduction
Endogenous endophthalmitis is a rare and visually devastating disease characterized 
by hematogenous dissemination of micro-organisms from a focus in the body, that in 
turn cross the blood-brain barrier and inoculate the intraocular tissues. Endogenous 
endophthalmitis has been well described in adults, but few cases have been reported 
in the neonatal population.
In a large case series of endophthalmitis occurring in children and young adults, 
the most common endophthalmitis category was in the setting of trauma.1 In contrast, 
endophthalmitis in infants is mostly endogenous and results perinatally from vertical 
transmission or postnatally from contaminated intravascular catheters, respiratory 
equipment, or caregivers.2–6 The most commonly described pathogens in neonatal 
endophthalmitis are Candida species, group B streptococci, Pseudomonas aeruginosa, 
and other Gram negative bacteria.7–11
Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
733
CASE SERIES
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/OPTH.S26362Clinical Ophthalmology 2012:6
Neonates in the neonatal intensive care unit (NICU) with 
a diagnosis of septicemia or fungemia are routinely screened 
to rule out ocular involvement. Risk factors of developing 
endophthalmitis in neonates include candidemia, bacteremia, 
retinopathy of prematurity, respiratory disorder, blood trans-
fusion, fetal hemorrhage, and low birth weight.12
The mainstay of treatment for endogenous endophthal-
mitis includes systemic antimicrobials with adjuvant 
intravitreal injections and pars plana vitrectomy in selected 
patients. In general, the visual prognosis is unfavorable, 
and the mortality rate is associated with virulence of 
the organisms causing underlying neonatal septicemia. 
Visual outcomes are generally more favorable among 
those surviving candidemia when compared with bacterial 
septicemia.13–17
Materials and methods
A retrospective review of the medical records was conducted 
for all patients admitted to the NICU at Jackson Memorial 
Hospital between March 1, 2002 and March 1, 2007. This 
study was approved by the internal review boards at the 
University of Miami Miller School of Medicine and Jackson 
Memorial Hospital, and all procedures were performed in 
accordance with the 1951 Declaration of Helsinki.18
The neonatology division of Jackson Memorial Hospital 
maintains a clinical database of all newborns admitted to 
the NICU. A pediatric retina specialist (AMB) conducted 
a dilated examination of the fundus when blood, urine, 
wound, or cerebrospinal fluid cultures confirmed systemic 
infection or as screening for retinopathy of prematurity. 
Indirect ophthalmoscopy with or without scleral depres-
sion was performed one hour after pupillary dilation. No 
infant was too ill to undergo complete ophthalmoscopic 
examination.
Neonatal patients with endophthalmitis were identified 
clinically by anterior segment findings and by the pres-
ence of characteristic vitreous opacities or chorioretinal 
infiltrates. Septicemia was confirmed in conjunction with 
the neonatologists by clinical signs of sepsis and posi-
tive blood, urine, cerebrospinal fluid, vitreous, or wound 
cultures, or polymerase chain reaction. Broad-spectrum 
antibiotics (ampicillin and gentamicin) and/or antifungals 
(fluconazole or amphotericin) were initiated when sepsis 
was suspected, and intravascular catheters were changed if 
blood cultures were positive. Intravitreal antibiotics and/or 
antifungals and vitreous surgery were performed when the 
initial clinical signs were severe or the vitritis worsened 
despite systemic treatment.
Results
Of 4323 infants admitted to the NICU at Jackson   Memorial 
Hospital during the 5-year study period, seven eyes of six 
infants (two males, four females) had endophthalmitis. 
Mean follow-up was 3.5 years. Four infants were transferred 
from an outside NICU for worsening systemic and ocular 
complications. Four patients were born prematurely with a 
mean gestational age of 27.5 weeks and a mean birth weight 
of 1153 g (three patients weighed #1000 g).
The four preterm infants had multiple comorbidities 
associated with prematurity, including bronchopulmonary 
dysplasia, hydrocephalus, intraventricular hemorrhage, 
anemia, rickets, and hypothyroidism. Each was screened 
for development of retinopathy of prematurity, which was 
found in two patients and required treatment. Two patients 
had tunica vasculosa lentis.
All six infants showed constitutional signs of infection, 
including fever, poor feeding, lethargy, worsening respira-
tory status, or bradycardia. Ophthalmologic consultation 
was sought immediately in five of six infants, and in these 
cases, the ophthalmologist used indirect ophthalmoscopy to 
confirm the diagnosis on the same day. The one infant with 
delayed consultation was constitutionally improving after 
three weeks of liposomal amphotericin B, and ophthalmol-
ogy consultation was sought only after corneal edema and 
leukocoria was noted in the right eye.
The mean number of postnatal days to time of positive 
culture was 34 (range 21–43). Cultures or polymerase chain 
reaction identified the pathogens in all cases. Although all 
patients were tested, only two patients had positive blood and 
urine cultures. Diagnostic extraocular cultures were obtained 
invasively from multiple sites in three patients, two from 
hepatic abscesses, and one from pleural fluid. Anterior cham-
ber polymerase chain reaction was positive in one patient. Ocu-
lar cultures were obtained in five patients, four from vitreous 
cultures, and two from removed ocular contents (enucleation 
and evisceration specimens). Cultures grew from multiple sites 
in four patients. Candida albicans was the causative   organism 
Figure 1 Fundus images of the right and left eyes of patient 4 with bilateral well 
circumscribed chorioretinal lesions in the macula. The lesion is more prominent in 
the right eye.
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in four patients (Figure 1). Pseudomonas aeruginosa and 
herpes simplex virus type 2 each caused endophthalmitis in 
one patient (Figure 2). All cases of C. albicans were sensitive 
to fluconazole, and the case of P . aeruginosa was sensitive to 
piperacillin and third-generation cephalosporins. Treatment 
and outcomes are summarized in Table 1.
Because long-term follow-up was not possible in all 
patients, visual acuity data cannot be presented. Of the 
seven eyes, two had very poor outcomes (one enucleation 
(Figure 3) and one evisceration). Other patients recovered 
with a normal-appearing posterior segment and no sign of 
recurrent infection.
Discussion
Although colonization of skin and respiratory passages and 
contamination of indwelling lines and catheters are common 
events in the NICU, endophthalmitis is a rare complication. 
Most cases are caused by endogenous pathogens transmit-
ted perinatally or during extended postnatal   hospitalization. 
Figure 2 Montage image of the fundus of patient 6 showing diffuse necrotizing 
retinitis and vitritis.
Table 1 Clinical features in neonates with endophthalmitis in the neonatal intensive care unit
Patient  
number/ 
gender
Age of birth  
(gestational week)/ 
birth weight (g)
Etiology Systemic  
treatment
Intravitreal  
injection
Interventional  
treatment
Other ophthalmic   
findings
1 (OD)/male 26 weeks/825 g Candida albicans Intravenous  
amphotericin B  
and fluconazole
Amphotericin B Pars plana  
vitrectomy/pars  
plana lensectomy  
with removal of  
pupillary membrane
Glaucoma* in right  
eye with Baerveldt  
tube implant
2 (OD)/female 25 weeks/870 g Candida albicans Intravenous  
amphotericin B  
and fluconazole
Amphotericin B Pars plana  
vitrectomy/pars  
plana lensectomy
Glaucoma* in the  
right eye with  
Baerveldt tube  
implant 
ROP in both eyes  
treated with laser  
ablative therapy
3 (OS)/female 37 weeks/3340 g Candida albicans Intravenous  
fluconazole
Amphotericin B Enucleation Glaucoma* in left  
eye (medically  
treated with  
acetazolamide) 
ROP in right eye  
treated with laser  
ablative treatment
4 (OD)/male 40 weeks/3225 g Candida albicans Intravenous  
amphotericin B,  
fluorocytosine,  
and fluconazole
Amphotericin B 
Voriconazole
Pars plana  
vitrectomy/pars  
plana lensectomy
4 (OS)/male 40 weeks/3325 g Candida albicans Intravenous  
amphotericin B,  
fluorocytosine,  
and fluconazole
Amphotericin B
5 (OD)/male 27 weeks/1000 g Pseudomonas  
aeruginosa
Intravenous  
piperacillin,  
ceftazidime,  
and gentamicin
Evisceration ROP
6 (OD)/female 32 weeks/1910 g Herpes simplex  
virus
Intravenous  
aciclovir
Notes: *Glaucoma developed in patient 1 at age 2 years, in patient 2 at 3 months of age, and patient 3 was referred from an outside institution at 2 months of age with a 
diagnosis of congenital glaucoma. 
Abbreviation: ROP, retinopathy of prematurity.
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Historically, rates of endophthalmitis from septicemia 
approached 50%.19 These rates have been dropping over 
the last three decades from a reported incidence of 8.71 
per 100,000 of live births per year in 1998 to only 4.42 per 
100,000 in 2006.12 Improvements in recognition and earlier 
empiric use of broad-spectrum antibiotics and antifungals 
for septicemia have possibly reduced the rate of neonatal 
endophthalmitis to infants whose infection was not suc-
cessfully controlled with intravenous therapies alone. Thus, 
in contrast with previously reported series, this cohort of 
patients required invasive vitreoretinal interventions for 
successful treatment of infection.
Infants in a NICU are at highest risk for septicemia and 
endophthalmitis. The presence of tunica vasculosa lentis may 
be an additional predisposing factor for endophthalmitis in 
very premature infants with septicemia. Infants with retin-
opathy of prematurity have increased vascular permeability 
because of upregulated vascular endothelial growth factor that 
may allow ocular seeding of septic emboli. Conversely, some 
authors have demonstrated an association between candidemia 
and progression to threshold retinopathy of prematurity.20,21
The severity of endophthalmitis presentation in the cur-
rent study may reflect timing of diagnosis relative to the 
onset of disease, the virulence of the causative pathogen, or a 
greater inoculum evading immune constraints.   Examinations 
are routinely performed on premature and very low birth 
weight infants for retinopathy of prematurity.22 In addition, 
early ophthalmologic consultation is advisable in those 
infants with constitutional symptoms of septicemia or ocular 
signs, such as corneal edema or leukocoria.
In a study from our institution of endogenous fungal 
endophthalmitis in adults, 65 eyes of 51 patients were 
treated. Visual outcomes were poor, especially when the 
endophthalmitis was caused by mold.23 Similar to the adult 
population, the visual prognosis of neonatal endogenous 
endophthalmitis is often poor, even with early identification 
and prompt intervention.
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